Acute Disseminated Encephalomyelitis With Anti Mog Antibodies C5680301
A form of demyelinating disease where immune cells target a specific protein called anti-MOG, affecting brain and spinal cord. Treatment involves suppressing the immune response.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Encephalopathy
Multifocal neurological deficits
Visual loss
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Cerebellar ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Corticosteroid Therapy
High-dose IV corticosteroids remain the cornerstone of initial treatment, effectively reducing acute inflammation and promoting recovery in anti-MOG antibody-associated demyelinating disease, though relapse monitoring is essential.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Immunoglobulin Therapy
IVIG provides immunomodulatory benefits and is particularly useful in pediatric patients with anti-MOG antibodies, often showing favorable response rates in acute demyelinating attacks.
Additional treatment options
Maintenance Immunosuppression
Long-term immunosuppression with agents such as mycophenolate or azathioprine may be considered for patients with recurrent anti-MOG demyelination to prevent future relapses.
medicationAnti-MOG Antibody Titer Monitoring
Regular serological monitoring of anti-MOG antibody titers helps track disease activity and guide treatment decisions, though correlation with clinical status should always be considered.
monitoringNeurorehabilitation Services
Early and ongoing rehabilitation including physical and occupational therapy addresses motor deficits, fatigue, and cognitive changes that may persist following demyelinating episodes.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Disseminated Encephalomyelitis With Anti Mog Antibodies C5680301?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
International Pediatric Multiple Sclerosis Study Group. Anti-MOG antibody-associated demyelinating disorders: consensus recommendations for diagnosis and management. Mult Scler Relat Disord. 2022.
Reindl M, Waters P, Rostasy K. Myelin oligodendrocyte glycoprotein antibody-associated disease: a review of current understanding and future prospects. Ann Neurol. 2023.
Hacohen Y, Brownlee W, Miller T, et al. Clinical characteristics and treatment outcomes in children with anti-MOG antibody-mediated acute disseminated encephalomyelitis. JAMA Neurol. 2021.
Jarius S, Paul F, Aktas O, et al. MOG antibody disease: a systematic review of longitudinal findings in adult and pediatric patients. Neurology. 2022.
Medication Comparisons
Compare medications used to treat Acute Disseminated Encephalomyelitis With Anti Mog Antibodies C5680301. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy